1-10 of 10
Ping Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

Anna E. Coghill, Ruth M. Pfeiffer, Carla Proietti, Wan-Lun Hsu, Yin-Chu Chien, Lea Lekieffre, Lutz Krause, Andy Teng, Jocelyn Pablo, Kelly J. Yu, Pei-Jen Lou, Cheng-Ping Wang, Zhiwei Liu, Chien-Jen Chen, Jaap Middeldorp, Jason Mulvenna, Jeff Bethony, Allan Hildesheim, Denise L. Doolan
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13): 3496.
https://doi.org/10.1158/1078-0432.CCR-20-1828
Published: 01 July 2020
View article titled, Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan
Open the PDF for Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan in another window
Journal Articles

Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia

Gang Heng, Jiankun Jia, Shiqi Li, Gang Fu, Meiling Wang, Dabing Qin, Yunyan Li, Li Pei, Xiaobo Tian, Jiasi Zhang, Yi Wu, Shali Xiang, Jia Wan, Wei Zhu, Pei Zhang, Qianzhen Zhang, Xi Peng, Linling Wang, Ping Wang, Zhihao Wei, Yingzi Zhang, Guiqin Wang, Xue Chen, Chengcheng Zhang, Yanni Sun, Wenxu Zhao, Yahan Fan, Zhi Yang, Jieping Chen, Cheng Qian
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (7): 1606–1615.
https://doi.org/10.1158/1078-0432.CCR-19-1339
Published: 01 April 2020
View article titled, Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia
Open the PDF for Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia in another window
Includes: Supplementary data
Journal Articles

Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

Anna E. Coghill, Ruth M. Pfeiffer, Carla Proietti, Wan-Lun Hsu, Yin-Chu Chien, Lea Lekieffre, Lutz Krause, Andy Teng, Jocelyn Pablo, Kelly J. Yu, PhD, Pei-Jen Lou, MD, Cheng-Ping Wang, Zhiwei Liu, Chien-Jen Chen, Jaap Middeldorp, Jason Mulvenna, Jeff Bethony, Allan Hildesheim, Denise L. Doolan
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1305–1314.
https://doi.org/10.1158/1078-0432.CCR-17-1929
Published: 14 March 2018
View article titled, Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan
Open the PDF for Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan in another window
Includes: Supplementary data
Journal Articles

High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma

Anna E. Coghill, Wei Bu, Hanh Nguyen, Wan-Lun Hsu, Kelly J. Yu, Pei-Jen Lou, Cheng-Ping Wang, Chien-Jen Chen, Allan Hildesheim, Jeffrey I. Cohen
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3451–3457.
https://doi.org/10.1158/1078-0432.CCR-15-2299
Published: 14 July 2016
View article titled, High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma
Open the PDF for High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma in another window
Includes: Supplementary data
Journal Articles

CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia

Feng-Ting Liu, Li Jia, Ping Wang, Timothy Farren, Hong Li, Xishan Hao, Samir G. Agrawal
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (10): 2462–2469.
https://doi.org/10.1158/1078-0432.CCR-15-1139
Published: 12 May 2016
View article titled, CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia
Open the PDF for CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia in another window
Includes: Supplementary data
Journal Articles

Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non–Small Cell Lung Cancers In Vitro and In Vivo

Zhen Tao, Justin M. Le Blanc, Chenguang Wang, Tingting Zhan, Hongqing Zhuang, Ping Wang, Zhiyong Yuan, Bo Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1): 122–133.
https://doi.org/10.1158/1078-0432.CCR-15-0589
Published: 03 January 2016
View article titled, Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non–Small Cell Lung Cancers <em>In Vitro</em> and <em>In Vivo</em>
Open the PDF for Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non–Small Cell Lung Cancers <em>In Vitro</em> and <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

Prognostic Utility of Anti-EBV Antibody Testing for Defining NPC Risk among Individuals from High-Risk NPC Families

Kelly J. Yu, Wan-Lun Hsu, Ruth M. Pfeiffer, Chun-Ju Chiang, Cheng-Ping Wang, Pei-Jen Lou, Yu-Juen Cheng, Patti Gravitt, Scott R. Diehl, Alisa M. Goldstein, Chien-Jen Chen, Allan Hildesheim
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1906–1914.
https://doi.org/10.1158/1078-0432.CCR-10-1681
Published: 31 March 2011
View article titled, Prognostic Utility of Anti-EBV Antibody Testing for Defining NPC Risk among Individuals from High-Risk NPC Families
Open the PDF for Prognostic Utility of Anti-EBV Antibody Testing for Defining NPC Risk among Individuals from High-Risk NPC Families in another window
Includes: Supplementary data
Journal Articles

Tamoxifen versus Aromatase Inhibitors for Breast Cancer Prevention

Wei Yue, Ji-Ping Wang, Yuebai Li, Wayne P. Bocchinfuso, Kenneth S. Korach, Prabu D. Devanesan, Eleanor Rogan, Ercole Cavalieri, Richard J. Santen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 925s–930s.
https://doi.org/10.1158/1078-0432.925s.11.2
Published: 01 September 2009
View article titled, Tamoxifen <em>versus</em> Aromatase Inhibitors for Breast Cancer Prevention
Open the PDF for Tamoxifen <em>versus</em> Aromatase Inhibitors for Breast Cancer Prevention in another window
Journal Articles

Antiangiogenic Properties of Gold Nanoparticles

Priyabrata Mukherjee, Resham Bhattacharya, Ping Wang, Ling Wang, Sujit Basu, Janice A. Nagy, Anthony Atala, Debabrata Mukhopadhyay, Shay Soker
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3530–3534.
https://doi.org/10.1158/1078-0432.CCR-04-2482
Published: 02 May 2005
View article titled, Antiangiogenic Properties of Gold Nanoparticles
Open the PDF for Antiangiogenic Properties of Gold Nanoparticles in another window
Journal Articles

Long-Term Exposure to Tamoxifen Induces Hypersensitivity to Estradiol

Lev M. Berstein, Ji-Ping Wang, Hong Zheng, Wei Yue, Mark Conaway, Richard J. Santen
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1530–1534.
https://doi.org/10.1158/1078-0432.CCR-0433-03
Published: 20 February 2004
View article titled, Long-Term Exposure to Tamoxifen Induces Hypersensitivity to Estradiol
Open the PDF for Long-Term Exposure to Tamoxifen Induces Hypersensitivity to Estradiol in another window